−1,290 KRW
−20.87 B KRW
3.48 B KRW
13.89 M
About Y-BIOLOGICS, INC
Sector
Industry
Headquarters
Daejeon
Website
Founded
2007
ISIN
KR7338840002
FIGI
BBG01JPDHD40
Y-Biologics, Inc. operates as a biopharmaceutical company, which engages in the research and development of antibody therapeutics. The firm’s products include Ymax ABL, a human antibody library and ALiCE, a novel format for bispecific T-cell engager antibodies. The company was founded on December 31, 2007 and is headquartered in Daejeon, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 338840 is 7,480 KRW — it has decreased by −3.36% in the past 24 hours. Watch Y-BIOLOGICS, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange Y-BIOLOGICS, INC stocks are traded under the ticker 338840.
338840 stock has fallen by −3.61% compared to the previous week, the month change is a −9.88% fall, over the last year Y-BIOLOGICS, INC has showed a −43.93% decrease.
338840 reached its all-time high on Dec 5, 2023 with the price of 23,800 KRW, and its all-time low was 6,400 KRW and was reached on Dec 10, 2024. View more price dynamics on 338840 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
338840 stock is 6.58% volatile and has beta coefficient of 1.05. Track Y-BIOLOGICS, INC stock price on the chart and check out the list of the most volatile stocks — is Y-BIOLOGICS, INC there?
Today Y-BIOLOGICS, INC has the market capitalization of 110.57 B, it has increased by 4.27% over the last week.
Yes, you can track Y-BIOLOGICS, INC financials in yearly and quarterly reports right on TradingView.
338840 net income for the last quarter is −151.19 M KRW, while the quarter before that showed −2.84 B KRW of net income which accounts for 94.68% change. Track more Y-BIOLOGICS, INC financial stats to get the full picture.
No, 338840 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 54.00 employees. See our rating of the largest employees — is Y-BIOLOGICS, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Y-BIOLOGICS, INC EBITDA is −7.52 B KRW, and current EBITDA margin is −223.86%. See more stats in Y-BIOLOGICS, INC financial statements.
Like other stocks, 338840 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Y-BIOLOGICS, INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Y-BIOLOGICS, INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Y-BIOLOGICS, INC stock shows the strong sell signal. See more of Y-BIOLOGICS, INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.